When a company brings an IPO, its shares first enter the market through the public issue. Before the shares list on the stock exchange, some traders deal in them through an unofficial market. This is called the grey market.
The price difference between the IPO issue price and the grey-market price is known as the grey-market premium, or GMP.
For example, suppose an IPO has an issue price of ₹500 per share. If traders quote the share at ₹550 in the grey market, the GMP is ₹50. If the grey-market price is ₹500, the GMP is zero.
A zero GMP, therefore, means the unofficial market price is close to the IPO issue price.
At first look, this may seem like bad news. But the real picture is more complex. Zero GMP can give some idea about short-term market sentiment, but it cannot tell you the full story about an IPO.
What Does Zero GMP Tell You?
A zero GMP usually points to limited excitement among grey-market traders. These traders do not seem ready to pay a clear premium above the issue price.
This can mean that market participants do not expect a strong listing gain. If an IPO has a large positive GMP, traders may expect the stock to list well above its issue price. When the GMP falls to zero, that extra confidence is absent.
It can also show a lack of strong short-term demand. The grey market often reacts to the mood around an IPO. If interest falls, the premium can also fall.
Zero GMP can also point to uncertainty. Traders may have doubts about the company, its valuation, the wider market, or the likely demand on the listing day.
However, this does not mean that every zero-GMP IPO is weak. It only shows that the grey market does not offer a clear premium at that point.
Zero GMP Does Not Mean Zero Listing Gain
One of the biggest mistakes investors make is to treat GMP as a fixed prediction for the listing price.
Suppose an IPO has an issue price of ₹500 and its GMP is zero. It does not mean the stock must list at ₹500.
The actual listing price comes from demand and supply on the stock exchange. The grey market is separate from the official exchange market and has far less depth.
The same IPO could list at ₹550, ₹500, or even ₹450. A zero GMP does not give a guaranteed listing price.
This is why investors should not use the GMP figure as if it were an official price forecast.
Zero GMP Does Not Mean the IPO Is Bad
Another common mistake is to assume that a zero premium means the company is a poor investment.
That conclusion would be too quick.
GMP mainly reflects short-term market sentiment. It does not measure the complete quality of a business.
A company can have strong revenue growth, healthy profits, good cash flow and low debt, yet still have zero GMP. This can happen if the IPO price looks high, the overall market is weak, or traders do not expect a quick listing gain.
The opposite can also happen. An IPO can have a high GMP because of strong short-term excitement, even when its valuation or business outlook needs a closer look.
So, GMP should be seen as one small part of the IPO analysis.
It Does Not Show Whether the IPO Is Fairly Valued
The issue price of an IPO needs a deeper check.
Investors should look at the company’s revenue and profit growth. They should also check profit margins, cash flow and debt. These numbers can help show whether the business has a solid financial base.
Valuation is another key factor. An investor should compare the IPO with similar listed companies. If the IPO asks for a much higher valuation than its peers, a zero GMP may not be the main concern. The bigger question may be whether the issue price itself is reasonable.
Return on equity, or ROE, and return on capital employed, or ROCE, can also help investors judge how well the company uses its capital.
The quality of the promoters and management also matters. Investors should know who controls the company and how the business has performed under the current management.
Subscription Data Matters Too
IPO subscription data can offer a wider view of demand.
Investors can look at the response from qualified institutional buyers, or QIBs, non-institutional investors, or NIIs, and retail investors.
These groups can show different levels of interest. Strong QIB demand, for example, can offer a useful signal about institutional interest. Retail demand can show how much attention the issue has received from individual investors.
Still, subscription numbers alone should not decide the investment. A very high subscription can result from several factors, and it does not guarantee a good stock after listing.
GMP and subscription data work better when investors view them along with the company’s financial results and valuation.
Why Can GMP Fall to Zero?
GMP can change as market conditions change.
At the start of an IPO, traders may show strong interest and quote a premium. Later, that premium can fall if demand weakens or if market sentiment changes.
A fall to zero can also happen when investors become more cautious about the company’s valuation. If the issue price looks expensive, traders may stop paying an extra amount in the grey market.
Broader stock-market conditions can also affect GMP. When the overall market faces pressure, investors may become less willing to pay a premium for a new issue.
Therefore, a zero GMP is not always a company-specific signal. It can also reflect the mood of the wider market.
GMP Is More Useful for Listing Expectations
The best way to use GMP is to treat it as a short-term sentiment signal.
If your main aim is a listing-day gain, zero GMP deserves attention. It suggests that the grey market does not expect a clear premium at that stage.
But if your aim is to hold the stock for several years, GMP should have much less weight.
For a long-term investor, the main questions are different. Is the business growing? Are profits healthy? Is debt under control? Is the valuation reasonable? Does the company have a strong position in its industry?
These questions matter far more than a temporary grey-market quote.
The Bottom Line
A zero GMP does not mean an IPO will list at the issue price. It does not mean the company is bad, and it does not prove that the IPO is expensive or cheap.
It mainly tells you that the unofficial market currently sees little or no premium above the issue price. That can point to limited short-term excitement, weaker speculative demand or uncertainty about the listing.
Investors should therefore avoid making an IPO decision from GMP alone.
A better approach is to combine GMP with subscription numbers, company financials, peer valuations, debt, cash flow, ROE, ROCE, promoter quality and the purpose of the IPO.
In simple terms, GMP can tell you about market mood, but it cannot tell you the whole story about the company.
If the goal is a quick listing gain, zero GMP is a cautious signal. If the goal is long-term wealth creation, the company’s business and valuation deserve much more attention than its grey-market premium.
ALSO READ: When ETF Diversification Still Means Five Stocks Dominate
